Prevalence of β-cell and Thyroid Autoantibody Positivity in Schoolchildren during Three-Year Follow-up

References

• Bachrach L., Foley T., Jr. Thyroiditis in children. Pediatr. Rev. 1989; 11: 184–91
   PubMedGoogle Scholar
• van Vielet G., Delange, Goiter F., thyroiditis. Pediatric Endocrinology, 2nd edn, Bertrand, Rappaport, Sizonenko. Williams & Wilkins, Baltimore 1993; 270–6
   Google Scholar
• Fisher D. The thyroid. Clinical Pediatric Endocrinology, S. Kaplan. Saunders, Philadelphia 1990; 87–126
   Google Scholar
• Baekkeskov S., Nielsen J. H, Marner B., Bilde T., Ludvigsson J., Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982; 298: 167–9
   PubMed Web of Science ®Google Scholar
• Baekkeskov S., Landin M., Kristensen J., Srikanta S., Bruining G., Mandrup-Poulsen T., et al. Antibodies to a Mr 64000 human islet cell antigen precede the clinical onset of insulin dependent diabetes. J. Clin. Invest 1987; 79: 926–34
   PubMed Web of Science ®Google Scholar
• Baekkeskov S., Aanstoot H. K., Christgau S., Reetz A., Solimena M., Cascalco M., et al. Identification of the 64k autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151–6
   PubMed Web of Science ®Google Scholar
• Christie M., Landin-Olsson M., Sundkvist G., Dahlquist G., Lernmark A. Antibodies to a Mr-64000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia 1988; 31: 597–602
   PubMed Web of Science ®Google Scholar
• Atkinson M., Maclaren N. Islet cell antigens in insulin-dependent diabetes. J. Clin. Invest 1993; 92: 1608–16
   PubMed Web of Science ®Google Scholar
• Palmer J. P., Asplin C. M., Clemons P., Lyen K., Tatpati O., Raghu P. K., et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337–9
   PubMed Web of Science ®Google Scholar
• Dean B. M, Becker F., McNally J. M, Tarn A. C, Schwartz G., Gale E. A.M., et al. Insulin antibodies in the prediabetic period: correlation with islet cell antibodiesdevelopment of diabetes. Diabetologia 1986; 29: 339–42
   PubMed Web of Science ®Google Scholar
• Wilkin T., Armitage M., Casey C., Pyke D., Hoskins P., Rodier M., et al. Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus. Lancet 1985; 1: 480–2
   PubMed Web of Science ®Google Scholar
• Palmer J. P., Lernmark Å. Pathophysiology of type 1 (insulin-dependent) diabetes. Diabetes Mellitus, H Rifkin, D. Porte. Elsevier, New York 1990; 414–35
   Google Scholar
• Lernmark Å. Islet cell antibodies-theoreticalpractical implications. Diabetic Medicin 1987; 4: 285–92
   PubMed Web of Science ®Google Scholar
• Bottazzo G. F, Florin-Christensen A., Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1279–83
   PubMed Web of Science ®Google Scholar
• Lendrum R., Walker G., Cudworth A. G, Theo-Phanides C, Pyke D. A, Bloom A., et al. Islet cell antibodies in diabetes mellitus. Lancet 1976; 2: 1273–6
   PubMed Web of Science ®Google Scholar
• Spencer K. M, Tarn A., Dean B. M, Lister J., Bottazzo G. F. Fluctuating islet cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes. Lancet 1984; 1: 764–6
   PubMed Web of Science ®Google Scholar
• Landing B., Pettit M., Wiens R., Knowles H., Guest G. Antithyroid AntibodyChronic Thyroiditis in Diabetes. J. Clin. Endocrinol. Metab 1963; 23: 119–20
   PubMed Web of Science ®Google Scholar
• Lindberg B., Ivarsson S. A., Ericsson U. B., Ljung R. High prevalence of thyroid antibodies at diagnosis of Type 1 diabetes mellitus in Swedish children. J. Lab. Clin. Med. 1997; 130: 585–9
   PubMed Web of Science ®Google Scholar
• Nuovo J., Baker J., Wartofsky L., Lukes Y., Burman K. Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease. Diabetes 1988; 37: 317–20
   PubMed Web of Science ®Google Scholar
• Kawasaki E., Abiru N., Yano M., et al. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J Autoimmun 1995; 8: 633–43
   PubMed Web of Science ®Google Scholar
• Vardi P., Modan-Mozes D., Ish-Shalom S., Soloveitzik L., Barzilai D., Modan M. Low titer, competitive insulin autoantibodies are spontaneously produced in autoimmune diseases of the thyroid. Diabetes Res. Clin. Pract 1993; 21: 161–6
   PubMed Web of Science ®Google Scholar
• Ng W., Thai A., Lui K., Cheah J. Occurrence of antibodies to insulin in patients with autoimmune thyroid disease. Ann. Acad. Med. Singapore 1993; 22: 544–8
   PubMedGoogle Scholar
• Lindberg B., Ahlfors O K., Carlsson A., Ericsson U. B., Landin-Olsson M., Lernmark A., et al. Prior exposure to measles, mumps,rubella - but not vaccination during adolescence - correlates to the prevalence of pancreaticthyroid autoantibodies. Pediatrics 1999; 104/e12: 1–5, [www http://www.pediatrics org/ cgi/content/full/104/l/el2]
   Web of Science ®Google Scholar
• Riley W. J, Maclaren N. K, Krischer J., Spillar R. P, Silverstein J. H, Schatz D. A., et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. TV. Engl. J. Med. 1990; 323: 1167–72
   PubMed Web of Science ®Google Scholar
• Bingley P. J, Christie M. R, Bonifacio E., Bonifanti R., Shattock M., Fonte M. T., et al. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994; 43: 1304–10
   PubMed Web of Science ®Google Scholar
• Lipton R., Atchison J., Dorman J., et al. Genetic, immunologicalmetabolic determinants of risk for Type 1 diabetes mellitus in families. Diabetic Medicine 1992; 9: 224–32
   PubMed Web of Science ®Google Scholar
• Bloom A., Hayes T., Gamble D. Register of newly diagnosed diabetic children. Br. Med. J. 1975; 2: 580–3
   PubMedGoogle Scholar
• Dahlquist G., Blom L., Lönnberg G. The Swedish childhood diabetes study - a multivariate analysis of risk determinants for diabetes in different age groups. Diabetohgia 1991; 34: 757–62
   PubMed Web of Science ®Google Scholar
• Schatz D., Krischer J., Home G., et al. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerful as in unaffected relatives. J. Clin. Invest 1994; 93: 2403–7
   PubMed Web of Science ®Google Scholar
• Lévy-Marchal C, Tichet J., Fajardy I., Gu X., Dubois F., Czernichow P. Islet cell antibodies in normal French schoolchildren. Diabetohgia 1992; 35: 577–82
   PubMed Web of Science ®Google Scholar
• Bingley P., Bonifacio E., Shattock M., et al. Can islet cell antibodies predict IDDM in the general population?. Diabetes Care 1993; 16: 43–50
   Web of Science ®Google Scholar
• Tandon N., Zhang L., Weetman A. HLA associations with Hashimoto's thyroiditis. Clin. Endocrinol 1991; 40: 3836
   Google Scholar
• Bazarova E., Efuni S., Polianskaia I., Fedoseeva G., Okeanova T. Association of antigens of the HLA systemHashimoto's thyroiditis. Probl. Endokrinol 1988; 34: 14–16
   PubMedGoogle Scholar
• Farid N., Thompson C. HLAautoimmune endocrine disease. Mol. Biol. Med. 1986; 3: 85–97
   PubMedGoogle Scholar
• Bogner U., Badenhoop K., Peters H., Schmieg D., Mayr W., Usadel K., et al. HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serologicalmolecular level. Autoimmunity 1992; 14: 155–8
   PubMed Web of Science ®Google Scholar
• Jenkins D., Penny M., Fletcher J., Jacobs K., Mijovic C, Franklyn J., et al. HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis. Clin. Endocrinol 1992; 37: 141–5, 1992
   PubMed Web of Science ®Google Scholar
• Wolf E., Spencer K., Cudworlh A. The genetic susceptibility to Type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association. Diabetohgia 1983; 24: 224–30
   PubMed Web of Science ®Google Scholar
• Platz P., Jacobson B., Morling N., et al. HLA-DDR-antigens in genetic analysis of insulin-dependent diabetes mellitus. Diabetohgia 1981; 21: 108–15
   PubMed Web of Science ®Google Scholar
• Grubin C. E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W. A, Li L., et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetohgia 1994; 37: 344–50
   PubMed Web of Science ®Google Scholar
• Falorni A., Örtqvist E., Persson B., Lernmark Å. Radioimmunoassays for glutamic acid decarboxylase (GAD65)GAD65 autoantibodies using 35S or 3H recombinant human ligands. J. Immunol. Meth 1995; 186: 89–99
   PubMed Web of Science ®Google Scholar
• Madsen O., Landin-Olsson M., Bille G., Sundkvist G., Lernmark Å., Dahlqvist G., et al. A two-colour immunofluorescence test with a monoclonal human proinsulin antibody improves the assay for islet cell antibodies. Diabetohgia 1986; 29: 115–18
   PubMed Web of Science ®Google Scholar
• Landin-Olsson M., Sundkvist G., Lernmark Å. Prolonged incubation in the two-colour immunofluorescence test increases the prevalencetitres of islet cell antibodies in Type 1 (insulin-dependent) diabetes mellitus. Diabetohgia 1987; 30: 327–32
   PubMed Web of Science ®Google Scholar
• Bonifacio E., Lernmark A., Dawkins, et al. Scrum exchangeuse of dilutions have improved precision of measurement of islet cell antibodies. J. Immunol. Meth 1988; 106: 83–8
   PubMed Web of Science ®Google Scholar
• Greenbaum C. J, Palmer J. P, Nagataki S., Yamaguchi Y., Molenaar J. L, Van Beers W. A., et al. Improved specificity of ICA assays in the fourth international immunology of diabetes serum exchange workshop. Diabetes 1992; 42: 1570–4
   Google Scholar
• Ericsson U. B., Larsson L, Murne A., Thorel I. A new sensitive immunosorbent radioassay for the detection of circulating antibodies to polypeptide hormonesprotein. Seand. J. Clin. Lab Invest 1984; 44: 487–93
   PubMed Web of Science ®Google Scholar
• Kockum I., Wassmuth R., Holmberg E., Michelsen B., Lernmark Å. HLA-DQ primarily confers protectionHLA-DR susceptibility in type 1 (insulin-dependent) diabetes in population-based affected familiescontrol. Am. J. Hum. Genet 1993; 53: 150–67
   PubMed Web of Science ®Google Scholar
• Olerup O., Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2h: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225–35
   PubMed Web of Science ®Google Scholar
• Christie M., Delovitch T. L. Persistence of antibodies to a 64,000-Mr islet cell protein after onset of type 1 diabetes. Diabetes 1990; 39: 653–9
   PubMed Web of Science ®Google Scholar
• Yokota I., Matsuda J., Naito E., Ito M., Shima K., Kuroda Y. Comparison of GADICA512/1A-2 antibodies atafter the onset of IDDM. Diabetes Care 1998; 21: 49–52
   PubMed Web of Science ®Google Scholar
• Sundkvist G., Hagopian W. A, Landin-Olsson M., Lernmark A, Ohlsson L., Ericsson C., et al. Islet cell antibodies (ICA) but not glutamic acid decarboxylase antibodies (GAD65-Ab) are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus (IDDM). J. Clin. Endocrinol. Metah 1994; 78: 1159–65
   PubMed Web of Science ®Google Scholar
• Landin-Olsson M., Palmer J., Lernmark A., et al. Predictive value of islet cellinsulin autoantibodies for type I (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabeticmatched control children. Diabetohgia 1992; 35: 1068–73
   PubMed Web of Science ®Google Scholar
• Casali P., Nakamura M., Ginsberg-Fcllener Notkins F. A. Frequency of B cells committed to the production of antibodies to insulin in newly diagnosed patients with IDDMgeneration of high affinity human monoclonal IgG to insulin. J Immunol 1990; 1: 3741–7
   Google Scholar
• Landin-Olsson M., Karlsson A., Dahlquist G., Blom L., Lernmark Å, Sundkvist G. Islet cellother organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one yearin matched controls. Diabetohgia 1989; 32: 387–95
   PubMed Web of Science ®Google Scholar
• Lévy-Marchal C, Dubois F., Noël M., Tichet J., Czernichow P. Immunogenetic. DeterminantsPrediction of IDDM in French schoolchildren. Diabetes 1995; 44: 1029–32
   PubMed Web of Science ®Google Scholar
• Boem B., Manfras B., eißler J., et al. Epidemiologyimmunogenetic background of islet cell antibody-positive nondiabetic schoolchildren. Diabetes 1991; 40: 1435–9
   PubMed Web of Science ®Google Scholar
• Karjalainen J. Islet cell antibodies as predictive markers for IDDM in children with high background incidence of disease. Diabetes 1990; 39: 1144–50
   PubMed Web of Science ®Google Scholar
• Riley W., Maclaren N. Islet-cell antibodies are seldom transient. Lancet 1984; i: 1351–2
   Google Scholar
• Gardas A. Laboratory tests: levels of T3, T4, TSHantithyroid gland autoantibodies in the Polish population. Endokrynol. Pol. 1991; 42: 353–8
   PubMedGoogle Scholar
• Ericsson U. B., Ivarsson S. A. Thyroglobulin autoantibodies in childrenadolescents: Its relation to thyroid disease. Peel. Asthma All Immunol 1989; 3: 233–6
   Google Scholar
• Verge C, Gianni R., Kawasaki E., et al. Number of autoantibodies rather than particular autoantibody specificities determines risk of Type 1 diabetes. J. Autoimm 1996; 9: 379–83
   PubMed Web of Science ®Google Scholar
• Christie M., Roll U., Payton M., Hatfield E., Ziegler A. Validity of screening for individuals at risk for type 1 diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 1997; 20: 965–70
   PubMed Web of Science ®Google Scholar